×   Holy Name (main site)   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   HN Medical Partners

Physician Profile

New Jersey Medical Group

Jason Lee, MD

Specialties:

- Gastrointestinal Oncology
- Medical Oncology
- Urologic Oncology
- Hematology
- Oncology

Office Location:
718 Teaneck Road Cancer Center, Teaneck, NJ 07666

Fax:

201-227-6002

Physician Profile

Medical Education

Rutgers University - Robert Wood Johnson Medical School

Internship

Hospital of the University of Pennsylvania

Residency

Hospital University of Pennsylvania

Fellowship

New York Presbyterian Hospital-Columbia Campus

Awards & Recognitions

Castle Connolly Top Doctor and Rising Star (2022, 2023)

About Me

Jason C. Lee, MD, is the Co-Director of the Urologic Oncology Program at Holy Name Medical Center. He is a board-certified and fellowship-trained hematologist/oncologist who is focused on providing compassionate, evidence-based care for his patients. He has a particular interest in the treatment of genitourinary and gastrointestinal malignancies, including cancers of the prostate, bladder, kidney, testicles, esophagus, stomach, liver, pancreas, colon, and rectum.

After receiving his bachelor's degree in biology from the Johns Hopkins University, he earned his medical doctorate degree from Rutgers University-Robert Wood Johnson Medical School. He then completed his internal medicine residency at the Hospital of the University of Pennsylvania, followed by his hematology/oncology fellowship at Columbia University Medical Center in New York City, where he served as Chief Fellow.

Dr. Lee uses his advanced training to provide patients with the best therapies, tailored to fit each individual's needs. He is focused on providing modern cancer care using a team-based and multidisciplinary approach. At the onset of providing care, he informs his patients of the supportive services that are available to them and how he can be a catalyst for preserving their quality of life.

Dr. Lee participates in clinical trials and has been published in a number of medical journals. He is a member of the American Board of Internal Medicine, American Society of Clinical Oncology, and the American Society of Hematology.